Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer

NCT02129257 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: AFLIBERCEPT
DRUG: Irinotecan
DRUG: 5-Fluorouracil
DRUG: Folinic Acid

Sponsor

Hellenic Cooperative Oncology Group

Collaborators

[object Object]